And so, another working week will soon come to an end. Not a moment too soon, yes? For those who think this may sound premature, there is a holiday tomorrow on this side of the pond, so we are getting a head start on our weekend daydreaming. Our agenda is rather modest, given the circumstances. We do hope to hang with a couple of the short people, promenade with our energetic mascot and catch up on our reading. And what about you? This is a fine time to enjoy the outdoors. You could also putter around your castle. Or reach out to someone feeling isolated. Well, whatever you do, have a grand time. Enjoy, but be safe and wear a mask. This virus will not just disappear. See you soon…
Top Trump administration health officials are seeking to reassure the public that any potential Covid-19 vaccine will only be approved if it is safe and that the fast-track process will not be influenced by political pressure, The Hill reports. To assuage some of that concern, the agency released a guidance that outlines conditions for approving a vaccine. Those include requiring any vaccine to be at least 50% more effective than a placebo in preventing the disease.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
